Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention.
作者： M. Laakso
DOI: 10.1046/J.1365-2796.2001.00789.X
关键词: Gastroenterology 、 Aspirin 、 Insulin resistance 、 Medicine 、 Internal medicine 、 Cholesterol 、 Type 2 diabetes 、 Endocrinology 、 Blood pressure 、 Diabetic angiopathy 、 Lipoprotein 、 Diabetes mellitus
摘要: … state of knowledge on how to treat and prevent CVD amongst patients with type 2 diabetes. … cardiac failure and elevated blood pressure (especially amongst type 2 diabetic patients with …
sci-hub.st 参考文章(55)
UK Prospective Diabetes Study Group, None, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ. ,vol. 317, pp. 703- 713 ,(1998)
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels The New England Journal of Medicine. ,vol. 339, pp. 1349- 1357 ,(1998) , 10.1056/NEJM199811053391902
Effects of an angiotensin-converting -enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients The New England Journal of Medicine. ,vol. 342, pp. 145- 153 ,(2000) , 10.1056/NEJM200001203420301
Johan Herlitz, Å Hjalmarson, Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial European Heart Journal. ,vol. 6, pp. 199- 226 ,(1985)
Johan Herlitz, Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients The Lancet. ,vol. 343, pp. 311- 322 ,(1994)
K. MALMBERG, J. HERLITZ, AÅ. HJAKMARSON, L. RYDÈN, Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies European Heart Journal. ,vol. 10, pp. 423- 428 ,(1989) , 10.1093/OXFORDJOURNALS.EURHEARTJ.A059505
Giulio Zuanetti, Roberto Latini, Aldo P. Maggioni, MariaGrazia Franzosi, Luigi Santoro, Gianni Tognoni, Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study. Circulation. ,vol. 96, pp. 4239- 4245 ,(1997) , 10.1161/01.CIR.96.12.4239
Jaakko Tuomilehto, Daiva Rastenyte, Willem H. Birkenhäger, Lutgarde Thijs, Riitta Antikainen, Christopher J. Bulpitt, Astrid E. Fletcher, Françoise Forette, Adiv Goldhaber, Paolo Palatini, Cinzia Sarti, Jan A. Staessen, Robert Fagard, Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension The New England Journal of Medicine. ,vol. 340, pp. 677- 684 ,(1999) , 10.1056/NEJM199903043400902
J. Stamler, O. Vaccaro, J. D. Neaton, D. Wentworth, , Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. ,vol. 16, pp. 434- 444 ,(1993) , 10.2337/DIACARE.16.2.434
H Sarlund, K Pyörälä, I Penttilä, M Laakso, Early abnormalities in coronary heart disease risk factors in relatives of subjects with non-insulin-dependent diabetes. Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 12, pp. 657- 663 ,(1992) , 10.1161/01.ATV.12.6.657